HPV testing for primary cervical cancer screening a health technology assessment
The objective of this health technology assessment (HTA) is to address the policy question by assessing the diagnostic test accuracy, clinical utility, safety, cost-effectiveness, patients' experiences and perspectives, ethical issues, and implementation issues of HPV testing as a primary scree...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2019, 2019 Mar
|
| Series: | CADTH optimal use report
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this health technology assessment (HTA) is to address the policy question by assessing the diagnostic test accuracy, clinical utility, safety, cost-effectiveness, patients' experiences and perspectives, ethical issues, and implementation issues of HPV testing as a primary screening tool for cervical cancer screening. This HTA was conducted to inform decision-making, policy development, capacity planning, and recommendations around primary HPV-based testing for cervical cancer screening |
|---|---|
| Physical Description: | 1 online resource illustrations |